Safety, Tolerability and PK of PXL770 in Healthy Male Subjects

NCT03395470 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Disease

Interventions

DRUG: PXL770
DRUG: Placebo
DRUG: Rosuvastatin

Sponsor

Poxel SA